Rectal Cancer in 2018: A Primer for the Gastroenterologist.

Am J Gastroenterol

Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada. Department of Hematology and Oncology, CancerCare Manitoba, Winnipeg, MB, Canada. Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Department of Surgery, University of Manitoba, Winnipeg, MB, Canada. Department of Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada.

Published: December 2018

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768608PMC
http://dx.doi.org/10.1038/s41395-018-0180-yDOI Listing

Publication Analysis

Top Keywords

rectal cancer
4
cancer 2018
4
2018 primer
4
primer gastroenterologist
4
rectal
1
0
1
primer
1
gastroenterologist
1

Similar Publications

Background: Few studies have explored the genetic changes and clinicopathological features of stage II/III gastric cancer (GC) patients with no tumor recurrence, early recurrence, or late recurrence after curative surgery.

Methods: In this study, 376 patients who underwent curative surgery for stage II/III GC were analyzed. The clinical and genetic features of patients with no recurrence, early recurrence (<2 years), and late recurrence (≥2 years) were compared.

View Article and Find Full Text PDF

Background: Lymphadenectomy for rectal cancer is clearly defined by total mesorectal excision (TME). The analogous surgical strategy for the colon, the complete mesocolic excision (CME), follows the same principles of dissection in embryologically predefined planes.

Method: This narrative review initially identified key issues related to lymphadenectomy of rectal and colon cancer.

View Article and Find Full Text PDF

The purpose of this study was to identify whether the preoperative hemoglobin to albumin ratio (HAR) could predict the prognosis of patients who underwent colorectal cancer (CRC) radical resection. This study enrolled 4018 consecutive CRC patients, calculating HAR as the hemoglobin count divided by albumin count. Patients were divided into the high and low HAR groups based on a cut-off value (0.

View Article and Find Full Text PDF

Prostate cancer (PCa) has high prevalence rates in men and is a leading cause of cancer-related death. Transrectal (TR) biopsy has traditionally been the gold standard for diagnosis, but transperineal (TP) biopsy is increasingly favoured due to its lower infection risk. However, debate remains regarding which method has superior cancer detection rates.

View Article and Find Full Text PDF

Objectives: The objective is to evaluate the efficacy of F-fluorodeoxyglucose positron emission tomography (F-FDG-PET) computed tomography (CT) in the evaluation of tumor response to preoperative/palliative chemoradiotherapy (CRT) for advanced colorectal cancer; including metastatic cancer at primary presentation and recurrent cancers with local and/or distant metastasis.

Materials And Methods: Fifty patients with advanced rectal cancer underwent two point imaging with 18 FDG PET-CT before and after 3 weeks of completion of preoperative/palliative CRT in between 2016 and 2022. Patients with locally recurrent cancer also underwent radical surgery.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!